Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1964 53
1965 67
1966 74
1967 121
1968 160
1969 310
1970 334
1971 369
1972 379
1973 402
1974 376
1975 282
1976 244
1977 200
1978 204
1979 206
1980 199
1981 181
1982 199
1983 177
1984 239
1985 264
1986 223
1987 384
1988 289
1989 312
1990 283
1991 270
1992 309
1993 309
1994 286
1995 237
1996 303
1997 239
1998 332
1999 248
2000 256
2001 282
2002 260
2003 293
2004 320
2005 312
2006 286
2007 294
2008 327
2009 326
2010 354
2011 361
2012 330
2013 360
2014 330
2015 331
2016 320
2017 296
2018 265
2019 136
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

14,538 results
Results by year
Filters applied: . Clear all
Page 1
Atopic dermatitis
Weidinger S, et al. Nat Rev Dis Primers 2018 - Review. PMID 29930242
Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda
Sebode M, et al. Liver Int 2018 - Review. PMID 28432836
The mainstay of autoimmune hepatitis treatment has, from its first description to the current time, consisted of predniso(lo)ne to induce remission, in combination with azathioprine, which is used to maintain it. ...
The mainstay of autoimmune hepatitis treatment has, from its first description to the current time, consisted of predniso(lo)ne to induce re …
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments
Terziroli Beretta-Piccoli B, et al. World J Gastroenterol 2017 - Review. PMID 28970719 Free PMC article.
Standard treatment is based on steroids and azathioprine, and leads to disease remission in 80%-90% of patients. Alternative first line treatment has been attempted with budesonide or cyclosporine, but their superiority compared to standard treatment remains to be demonstrated. ...Mycophenolate mofetil is the most widely used second-line drug, and has good efficacy particularly for patients intolerant to azathioprine, but has the major disadvantage of being teratogenic. ...
Standard treatment is based on steroids and azathioprine, and leads to disease remission in 80%-90% of patients. Alternative first li …
The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.
Inman GJ, et al. Nat Commun 2018. PMID 30202019 Free PMC article.
Mutational signature analysis reveals the presence of a novel signature (signature 32), whose incidence correlates with chronic exposure to the immunosuppressive drug azathioprine. ...
Mutational signature analysis reveals the presence of a novel signature (signature 32), whose incidence correlates with chronic exposure to …
Pemphigus
Schmidt E, et al. Lancet 2019 - Review. PMID 31498102
Immunosuppressive treatment for proliferative lupus nephritis
Tunnicliffe DJ, et al. Cochrane Database Syst Rev 2018 - Review. PMID 29957821 Free PMC article.
In maintenance therapy, disease relapse is probably increased with azathioprine compared with MMF (RR 1.75, 95% CI 1.20 to 2.55; 114 more (30 to 236 more) per 1000 people (moderate certainty evidence). ...Azathioprine may increase disease relapse as maintenance therapy compared with MMF....
In maintenance therapy, disease relapse is probably increased with azathioprine compared with MMF (RR 1.75, 95% CI 1.20 to 2.55; 114 …
14,538 results
Jump to page
Feedback